An international group of researchers has voted to modify the scientific names of more than 200 plant species whose names carry a derogatory word.

Early in life, the protein Reelin helps assemble the brain. Later on, it appears to protect the organ from Alzheimer’s and other threats to memory and thinking.

On a rocky hillside in Colorado is a “mega den” of hundreds of rattlesnakes — along with cameras livestreaming the whole thing.

A fossil of an armadillo-like mammal appears to bear cut marks from butchering by humans, suggesting people were living in South America at least 20,000 years ago, even earlier than once thought.

Scientists scanned the brains of people who took psilocybin, including a member of the research team. The scans showed how the drug disrupts key networks, potentially enhancing brain plasticity.

Scientists have created a new tool that can give 5 minutes advance warning of a dangerous rogue wave in the ocean.

A study finds that carrion crows can be taught to count and make vocalizations that indicate the number counted, much in the same way that human toddlers do.

For decades, tianeptine was used to treat depression, even though no one knew how it worked. But it turns out it's a type of opioid, and the U.S. is facing a spike in abuse of "gas station heroin."

Amateur writers using AI tools produced stories that were deemed more creative, but the research suggests the creativity of the group overall went down.

A report from Nature shows that astronomers may have found a medium-sized black hole, a kind they've long looked for.

Longevity researchers are taking a generic drug they think may help extend people's lives. Now a dentist is testing if rapamycin stops gum disease — a canary in the coal mine for age-related diseases.

When dinosaurs reigned some 130 million years ago, flowering plants were taking over the world. That change is sealed in ancient amber specimens on the slopes of Lebanon that Danny Azar knows so well.

People with post-traumatic stress disorder (PTSD) may soon have a new treatment option: MDMA, the chemical found in ecstasy. In August, the Food and Drug Administration plans to decide whether MDMA-assisted therapy for PTSD will be approved for market based on years of research. But serious allegations of research misconduct may derail the approval timeline.

NPR science reporter Will Stone talks to host Emily Kwong about the clinical trials on MDMA-assisted therapy research and a recent report questioning the validity of the results.

Read Will's full story here.

Former President Donald Trump reiterated many of claims — without evidence — that his criminal trial was rigged, a day after a New York jury found him guilty of 34 counts of falsifying business records.

The new study has scientists concerned that microplastics may be contributing to reproductive health issues.